Latest Breaking News On - Abstracts leading - Page 1 : comparemela.com

Primary Ciliary Dyskinesia Clinical Trial Results Released

Primary Ciliary Dyskinesia Clinical Trial Results Released
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Jamesc moeserThomasw ferkol jrRichard boucherDepartment of pediatricsParion sciences incEuropean respiratory society international congressParion science incMarsico lung instituteParion sciencesLancet respiratory medicineEminent distinguished professorLung instituteAbstracts leadingRespiratory medicine trials

Researchers release results from clinical trial for treatment of primary ciliary dyskinesia

Researchers release results from clinical trial for treatment of primary ciliary dyskinesia
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Felixc ringshausenThomasw ferkol jrParion sciences incDepartment of pediatricsEuropean respiratory society international congressParion sciencesLancet respiratory medicineAbstracts leadingRespiratory medicine trialsLancet respiratory

Bristol Myers Squibb s Investigational LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressive Pulmonary Fibrosis Cohort of Phase 2 Study

Results show 26 weeks of treatment with twice-daily 60 mg dose of BMS-986278 resulted in a 69% relative reduction in the rate of decline in percent predicted forced vital capacity versus placeboTreatment effect was consistent with or without background therapy and BMS-986278 was well tolerated, with rates of adverse.

United statesBristol myers squibbTameraj corteJonathan sadehDepartment of respiratory medicineAmerican thoracic societyImmunology developmentEuropean respiratory societyInternational congressExchange commissionAbstracts leadingRespiratory medicine trialsProfessor tameraConsultant respiratory physicianInterstitial lung diseaseRespiratory medicine

Bristol Myers Squibb s Investigational LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressive Pulmonary Fibrosis Cohort of Phase 2 Study | National Business

PRINCETON, N.J. (BUSINESS WIRE) Sep 9, 2023

United statesJonathan sadehTameraj corteBristol myers squibbExchange commissionEuropean respiratory societyImmunology developmentDepartment of respiratory medicineInternational congressAmerican thoracic societyMyers squibbAbstracts leadingRespiratory medicine trialsProfessor tameraConsultant respiratory physicianInterstitial lung disease

Bristol-Myers Squibb s (BMY) LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressive Pulmonary Fibrosis Cohort of Phase 2 Study

Bristol-Myers Squibb s (BMY) LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressive Pulmonary Fibrosis Cohort of Phase 2 Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBristol myers squibbTameraj corteJonathan sadehDepartment of respiratory medicineImmunology developmentEuropean respiratory societyAmerican thoracic societyInternational congressExchange commissionAbstracts leadingRespiratory medicine trialsProfessor tameraConsultant respiratory physicianInterstitial lung diseaseRespiratory medicine